The mindbodygreen Podcast cover image

480: The longevity treatment no one’s talking about | Peter Attia, M.D.

The mindbodygreen Podcast

00:00

The Importance of Causality in Cardiovascular Disease

The general guideline says, unless that level reaches 5%, the cost of treating is not worth it. "I fundamentally disagree that a five to 10 year risk horizon is adequate," he said. He takes two drugs: Previs statin and PCSK9 inhibitor Repatha.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app